Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

GNC-New York Agreement Spurs States’ Call To Tighten Supplement Industry Scrutiny

This article was originally published in The Tan Sheet

Executive Summary

The agreement, which follows a recall based on the New York AG’s testing of herbal supplements purchased from GNC, could spur other states to look at requirements that exceed FDA’s supplement GMPs. NY AG Schneiderman says his “investigation raised questions regarding the sufficiency” of FDA regulations “in relation to state consumer protection laws.”

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

PS107595

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel